Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C3 and Gemcitabine in Advanced Pancreatic Cancer
NCT06030622Phase 2Recruiting
- Sponsor
- SUNY Downstate Health Sciences University
- Start
- Apr 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs), digoxin, simvastatin in pancreatic cancer (PC), sponsored by SUNY Downstate Health Sciences University. Started Apr 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)digoxinsimvastatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06030622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06030622.